F. Kajumo

发表

A binding pocket for a small molecule inhibitor of HIV-1 entry within the transmembrane helices of CCR5.

S. O. Smith, S W Lin, A. Trkola, 2000, Proceedings of the National Academy of Sciences of the United States of America.

Residues in a Highly Conserved Claudin-1 Motif Are Required for Hepatitis C Virus Entry and Mediate the Formation of Cell-Cell Contacts

T. Dragic, F. Kajumo, L. Meertens, 2009, Journal of Virology.

Thrombin stimulates tumor-platelet adhesion in vitro and metastasis in vivo.

S. Karpatkin, F. Kajumo, M. Nierodzik, 1991, The Journal of clinical investigation.

Immunodeficiency Virus Type 1 and Dualtropic Isolates of Human CCR5 Differently Impair Entry of Macrophage- Residues in the Amino-Terminal Domain of Alanine Substitutions of Polar and Nonpolar

G. Rabut, J. Konner, T. Dragic, 2012 .

Entry of R5X4 and X4 human immunodeficiency virus type 1 strains is mediated by negatively charged and tyrosine residues in the amino-terminal domain and the second extracellular loop of CXCR4.

D. Thompson, Daniah A. D. Thompson, T. Dragic, 2000, Virology.

Amino-Terminal Substitutions in the CCR5 Coreceptor Impair gp120 Binding and Human Immunodeficiency Virus Type 1 Entry

William C. Olson, Thomas P. Sakmar, A. Trkola, 1998, Journal of Virology.

Differential Inhibition of Human Immunodeficiency Virus Type 1 Fusion, gp120 Binding, and CC-Chemokine Activity by Monoclonal Antibodies to CCR5

William C. Olson, Yong Guo, Jeremy P. Segal, 1999, Journal of Virology.

Analysis of the Mechanism by Which the Small-Molecule CCR5 Antagonists SCH-351125 and SCH-350581 Inhibit Human Immunodeficiency Virus Type 1 Entry

Thomas P. Sakmar, Christoph Seibert, A. Trkola, 2003, Journal of Virology.

CD81 is an entry coreceptor for hepatitis C virus.

T. Dragic, E. Cormier, F. Kajumo, 2004, Proceedings of the National Academy of Sciences of the United States of America.

Effect of thrombin treatment of tumor cells on adhesion of tumor cells to platelets in vitro and tumor metastasis in vivo.

S. Karpatkin, F. Kajumo, M. Nierodzik, 1992, Cancer research.

Hepatitis C Virus Envelope Glycoprotein E2 Glycans Modulate Entry, CD81 Binding, and Neutralization

E. Falkowska, J. Reinus, Tatjana Dragic, 2007, Journal of Virology.

Alanine Substitutions of Polar and Nonpolar Residues in the Amino-Terminal Domain of CCR5 Differently Impair Entry of Macrophage- and Dualtropic Isolates of Human Immunodeficiency Virus Type 1

John P. Moore, G. Rabut, J. Konner, 1998, Journal of Virology.

Edie Garcia , John Neutralization andGlycans Modulate Entry , CD 81 Binding , Hepatitis C Virus Envelope Glycoprotein E 2

E. Falkowska, J. Reinus, T. Dragic, 2007 .

A Recombinant Human Immunodeficiency Virus Type 1 Envelope Glycoprotein Complex Stabilized by an Intermolecular Disulfide Bond between the gp120 and gp41 Subunits Is an Antigenic Mimic of the Trimeric Virion-Associated Structure

J. Binley, John P. Moore, B. Clas, 2000, Journal of Virology.

Expressionof Unmodified Hepatitis C Virus Envelope Glycoprotein-Coding SequencesLeads to Cryptic Intron Excision and Cell Surface Expression of E1/E2Heterodimers Comprising Full-Length and Partially DeletedE1

J. Roy-Chowdhury, I. Fox, J. Dumonceaux, 2003, Journal of Virology.

Expression of Unmodiﬁed Hepatitis C Virus Envelope Glycoprotein-Coding Sequences Leads to Cryptic Intron Excision and Cell Surface Expression of E1/E2 Heterodimers Comprising Full-Length and Partially Deleted E1

J. Roy-Chowdhury, I. Fox, J. Dumonceaux, 2003 .

CD 81 is an entry coreceptor for hepatitis C virus

T. Dragic, E. Cormier, F. Kajumo, 2004 .

Variable-Loop-Deleted Variants of the Human Immunodeficiency Virus Type 1 Envelope Glycoprotein Can Be Stabilized by an Intermolecular Disulfide Bond between the gp120 and gp41 Subunits

J. Binley, John P. Moore, R. Sanders, 2000, Journal of Virology.

CCR5-Mediated Human Immunodeficiency Virus Entry Depends on an Amino-Terminal gp120-Binding Site and on the Conformational Integrity of All Four Extracellular Domains

Yong Guo, Daniah A. D. Thompson, Yong Guo, 1999, Journal of Virology.

An anti-CCR5 monoclonal antibody and small molecule CCR5 antagonists synergize by inhibiting different stages of human immunodeficiency virus type 1 entry.

T. Dragic, F. Kajumo, Xavier Carnec, 2006, Virology.

A Recombinant Human Immunodeficiency Virus Type 1 Envelope Glycoprotein Complex Stabilized by an Intermolecular Disulfide Bond between the gp120 and gp41 Subunits Is an Antigenic Mimic of the Trimeric Virion-Associated Structure

J. Binley, John P. Moore, B. Clas, 2000, Journal of Virology.

Hepatitis C Virus Envelope Glycoprotein E2 Glycans Modulate Entry, CD81 Binding, and Neutralization

E. Falkowska, J. Reinus, T. Dragic, 2007, Journal of Virology.